Evidence map›Paper›PMID 34944777›Full record

ArticleCancers2021

Ankita Nachankar, Takahiro Oike, Hirofumi Hanaoka, Ayaka Kanai, Hiro Sato, Yukari Yoshida, Hideru Obinata, Makoto Sakai, Naoto Osu, Yuka Hirota and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ankita NachankarDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.ORCID 0000-0002-3742-8794
Takahiro OikeDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
Hirofumi HanaokaDepartment of Radiotheranostics, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
Ayaka KanaiDepartment of Radiotheranostics, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
Hiro SatoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.ORCID 0000-0001-8267-6917
Yukari YoshidaGunma University Heavy Ion Medical Center, Maebashi 371-8511, Japan.
Hideru ObinataLaboratory for Analytical Instruments, Education and Research Support Center, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
Makoto SakaiGunma University Heavy Ion Medical Center, Maebashi 371-8511, Japan.ORCID 0000-0001-9928-2375
Naoto OsuDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.ORCID 0000-0002-2288-253X
Yuka HirotaDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.
Akihisa TakahashiGunma University Heavy Ion Medical Center, Maebashi 371-8511, Japan.ORCID 0000-0002-9960-2153
Atsushi ShibataSignal Transduction Program, Gunma University Initiative for Advanced Research (GIAR), Maebashi 371-8511, Japan.ORCID 0000-0001-8912-6977
Tatsuya OhnoDepartment of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.ORCID 0000-0002-6703-3144
Gunma University · JPGunma University Hospital · JP

Funding

Ministry of Education, Culture, Sports, Science, and Technology of Japan JPMXS0420600120
6 · The paper itself

Abstract

Carbon ion radiotherapy is an emerging cancer treatment modality that has a greater therapeutic window than conventional photon radiotherapy. To maximize the efficacy of this extremely scarce medical resource, it is important to identify predictive biomarkers of higher carbon ion relative biological effectiveness (RBE) over photons. We addressed this issue by focusing on cellular antioxidant capacity and investigated

Indexed as

64Cu-ATSMantioxidant systemscarbon ion radiotherapyreactive oxygen speciesrelative biological effectiveness

Identifiers

PMID34944777
PMCPMC8699283
OpenAlexW4200008927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.